Both in Pharmaceuticals
Jazz Pharmaceuticals vs BridgeBio Pharma
Over the past year JAZZ returned +70.3% and BBIO returned +26.9%; their daily moves had a correlation of 0.20.
JAZZ +70.3% BBIO +26.9%Growth of $1, one year, split-adjusted
| Metric | JAZZ | BBIO |
|---|---|---|
| Price | $234.66 | $77.89 |
| Market cap | $15.23B | $15.17B |
| Today | +2.14% | +5.21% |
| 1 month | +1.4% | +16.3% |
| 6 months | +2.7% | +14.4% |
| Year to date | +38.0% | +1.8% |
| 1 year | +69.6% | +25.7% |
| Revenue growth (YoY) | +10.4% | +192.6% |
| Gross margin | 91.1% | 94.2% |
| Net margin | −38.9% | −23.5% |
| P/E (TTM) | 74.0× | — |
| Price / sales | 3.2× | 16.0× |
| Net cash | -$2.71B | -$938.6M |
| Dividend yield | — | — |
| Volatility (60d) | 31.2% | 34.1% |
| Short % of float | 9.4% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).